In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Iterum Therapeutics Plc (NASDAQ: ITRM) was $0.63 for the day, down -1.72% from the previous closing price of $0.64. In other words, the price has decreased by -$1.72 from its previous closing price. On the day, 0.52 million shares were traded. ITRM stock price reached its highest trading level at $0.6599 during the session, while it also had its lowest trading level at $0.6108.
Ratios:
Our analysis of ITRM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 2.69.
On March 15, 2021, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $2.50.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on June 02, 2020, whereas the target price for the stock was revised from $7 to $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 08 ’25 when Dunne Michael W. bought 15,000 shares for $0.72 per share. The transaction valued at 10,854 led to the insider holds 235,001 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITRM now has a Market Capitalization of 28089190 and an Enterprise Value of 47621192.
Stock Price History:
The Beta on a monthly basis for ITRM is 3.25, which has changed by -0.43839288 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, ITRM has reached a high of $3.02, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is -25.19%, while the 200-Day Moving Average is calculated to be -50.56%.
Shares Statistics:
ITRM traded an average of 796.53K shares per day over the past three months and 797700 shares per day over the past ten days. A total of 44.66M shares are outstanding, with a floating share count of 43.68M. Insiders hold about 2.19% of the company’s shares, while institutions hold 4.57% stake in the company. Shares short for ITRM as of 1755216000 were 1567017 with a Short Ratio of 1.97, compared to 1752537600 on 1839526. Therefore, it implies a Short% of Shares Outstanding of 1567017 and a Short% of Float of 3.54.
Earnings Estimates
The current rating of Iterum Therapeutics Plc (ITRM) is the result of assessments by 1.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $0.01, with high estimates of $0.01 and low estimates of $0.01.
Analysts are recommending an EPS of between -$0.33 and -$0.33 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.09, with 2.0 analysts recommending between $0.1 and -$0.27.
Revenue Estimates
Based on 2 analysts’ estimates, the company’s revenue will be $16.3M in the next fiscal year. The high estimate is $17.5M and the low estimate is $15.1M.
